|Day Low/High||15.32 / 15.61|
|52 Wk Low/High||12.30 / 19.01|
Shares surge after the poultry producer tops earnings forecasts.
In this Street Insight special, Chris Atayan reveals some potential acquisition candidates.
Pfizer's lump of coal failed to prevent solid overall results in the holiday portfolio in 2004.
Despite Pfizer's drag, the portfolio has worked as planned, thanks largely to ConocoPhillips.
There's a whole basket of plays on the attraction this group holds for growth-hungry European institutions.
Some of these stocks look energized, while one real estate name needs a spark.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.